Seeking Alpha

Salix Pharmaceuticals (SLXP): Q1 EPS of $0.67 beats by $0.11. Revenue of $171.1M (+62% Y/Y). (PR)

Salix Pharmaceuticals (SLXP): Q1 EPS of $0.67 beats by $0.11. Revenue of $171.1M (+62% Y/Y). (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs